AMG
SQZ

Advisors Management Group’s SQZ Biotechnologies Company SQZ Stock Holding History

Advisors Management Group’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,000
Closed -$10K – 149
2022
Q4 		$10K Buy
+14,000
New +$30.6K ﹤0.01% 131

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Advisors Management Group's SQZ Position: Q1 2023 in Review

Advisors Management Group sold out of SQZ Biotechnologies Company (SQZ) in Q1 2023, closing a stake of 14,000 shares — an estimated $10K sold.

Advisors Management Group first reported a position in SQZ in Q4 2022 and held it in 1 quarter. The position peaked at $10K in Q4 2022. 32 funds tracked by Wall St. Rank hold SQZ as of Q1 2023.

  • Advisors Management Group reported no remaining SQZ Biotechnologies Company position as of Q1 2023 after selling out during the quarter.
  • Advisors Management Group sold 14,000 SQZ Biotechnologies Company shares in Q1 2023, an estimated $10K.
  • Advisors Management Group first reported a position in SQZ Biotechnologies Company in Q4 2022 and held it in 1 quarter.
  • Advisors Management Group's SQZ Biotechnologies Company position peaked at $10K in Q4 2022.
  • 32 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q1 2023.

Based on Advisors Management Group's 13F filing for Q1 2023, filed 26 Apr 2023.